Biotech

All Articles

Former Seagen CEO unveils brand-new start-up Ottimo Pharma

.After antibody-drug conjugate (ADC) expert Seagen was actually sold to Pfizer in 2014 for a monstro...

Ironwood creates additional purpose $1B GI medicine along with brand new subgroup data

.On the heels of a period 3 succeed that stopped working to wow real estate investors, Ironwood Phar...

Novartis inks $150M deal for autoimmune molecular glue

.Do not cease Monte Rosa Therapeutics currently. The Boston-based biotech is actually having a ball ...

Jade carves out exec team along with Chinook veterinarians-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our summary of considerable management hirings, shooting...

Septerna goes social along with upsized offering of $288M

.Commemorating his firm's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer called t...

AbbVie brings in Richter richer, paying for $25M to constitute discovery contract

.AbbVie has actually returned to the source of its antipsychotic goliath Vraylar searching for anoth...

GenSight enters final weeks of cash path as earnings flow noses out of range

.GenSight Biologics is actually weeks out of losing amount of money. Once again. The biotech simply ...

AZ licenses thrown away uncommon health condition drug to Monopar Therapies

.Monopar Therapies is recuperating a medication coming from the scrap heap of AstraZeneca's unusual ...

Arcus' brand-new HIF-2a records in renal cancer hint at prospective upper hand over Merck's Welireg, analysts state

.Along with brand-new information out on Arcus Biosciences' speculative HIF-2a prevention, one group...

Roche bets around $1B to increase Dyno genetics treatment delivery deal

.After developing a gene therapy partnership with Dyno Therapeutics in 2020, Roche is back for more....